UPDATE: Canaccord Genuity Reiterates Buy Rating, Raises PT on Insulet Corporation

Loading...
Loading...
In a report published Friday, Canaccord Genuity reiterated its Buy rating on Insulet Corporation
PODD
, and raised its price target from $24.50 to $29.00. Canaccord Genuity noted, “We are reiterating our BUY rating on Insulet and naming it one of our top growth picks for 2013. We believe a new product cycle could not only drive accelerating revenue growth, but also result in significant improvements in operating results. Furthermore, already operating cash flow positive in Q4/12, we believe the company is well positioned to become FCF positive in 2013 and EPS positive in 2014.” Insulet Corporation closed on Thursday at $21.23.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsCanaccord Genuity
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...